(Reuters) – Russia’s sovereign wealth fund has filed for registration of Sputnik V in the European Union and expects it to be reviewed in February, the official account promoting the COVID-19 vaccine tweeted on Wednesday.
The Sputnik V and European Medical Agency (EMA) teams held a scientific review of the vaccine on Tuesday, the Sputnik V account said, adding the EMA will take a decision on the authorization of the vaccine based on the reviews.
The vaccine has already been approved in Argentina, Belarus, Serbia and other countries.
(Reporting by Amruta Khandekar; Editing by Shinjini Ganguli)
